Development of Prognostic Models for Response and Toxicity to CAR-T Cell Therapy in Patients with Relapsed/refractory Non Hodgkin's Lymphoma.
Clinical trial NCT06720701 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06720701
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-12-01
- Primary completion
- 2026-12-31
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.